Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2010-05-17 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PLOGOFF (29770), Finistere
PHARMACIE DU BOUT DU MONDE : revenue, balance sheet and financial ratios
PHARMACIE DU BOUT DU MONDE is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PLOGOFF (29770),
this company of category PME
shows in 2023 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU BOUT DU MONDE (SIREN 522496199)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 723 237 €
1 689 377 €
1 623 296 €
1 189 793 €
1 241 241 €
1 203 074 €
1 273 923 €
1 228 480 €
Net income
79 036 €
35 197 €
50 209 €
60 916 €
70 380 €
84 997 €
48 950 €
60 351 €
84 270 €
EBITDA
N/C
66 203 €
81 307 €
86 448 €
86 518 €
118 250 €
88 392 €
102 530 €
137 119 €
Net margin
N/C
2.0%
3.0%
3.8%
5.9%
6.8%
4.1%
4.7%
6.9%
Revenue and income statement
In 2024, PHARMACIE DU BOUT DU MONDE generates positive net income of 79 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 84 k€ -> 79 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
79 036 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
46.303%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.895%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU BOUT DU MONDE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
93.845
73.591
58.285
40.784
28.822
79.612
72.114
60.875
46.303
Financial autonomy
44.138
46.99
53.043
60.115
65.591
47.978
48.584
52.848
56.895
Repayment capacity
4.619
4.648
4.479
2.618
2.347
7.493
7.609
10.043
None
Cash flow / Revenue
8.008%
6.371%
5.728%
7.31%
6.416%
4.283%
3.783%
2.495%
None%
Sector positioning
Debt ratio
46.32024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-6 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU BOUT DU MONDE (46.30) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
56.9%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+7 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU BOUT DU MONDE (56.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
10.04 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DU BOUT DU MONDE (10.04) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 119.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
119.423
Liquidity indicators evolution PHARMACIE DU BOUT DU MONDE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
229.824
185.845
182.076
178.526
166.967
160.346
106.966
108.639
119.423
Interest coverage
10.654
11.986
11.287
6.342
4.843
7.527
6.516
8.444
None
Sector positioning
Liquidity ratio
119.422024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of PHARMACIE DU BOUT DU MONDE (119.42) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
8.44x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE DU BOUT DU MONDE (8.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU BOUT DU MONDE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
173 584 €
187 228 €
151 106 €
130 392 €
143 739 €
153 207 €
124 490 €
155 350 €
0 €
Inventory turnover (days)
39
40
34
35
38
29
29
29
0
Customer payment term (days)
6
5
5
4
4
4
3
5
0
Supplier payment term (days)
54
67
61
50
52
48
53
45
0
Positioning of PHARMACIE DU BOUT DU MONDE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU BOUT DU MONDE is estimated at
1 103 400 €
(range 768 391€ - 1 650 751€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
768k€1103k€1650k€
1 103 400 €Range: 768 391€ - 1 650 751€
NAF 5 année 2024
Valuation method used
Net Income Multiple
79 036 €
×
14.0x
=1 103 401 €
Range: 768 391€ - 1 650 751€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU BOUT DU MONDE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU BOUT DU MONDE
What is the revenue of PHARMACIE DU BOUT DU MONDE ?
The revenue of PHARMACIE DU BOUT DU MONDE in 2023 is 1.7 M€.
Is PHARMACIE DU BOUT DU MONDE profitable?
Yes, PHARMACIE DU BOUT DU MONDE generated a net profit of 79 k€ in 2024.
Where is the headquarters of PHARMACIE DU BOUT DU MONDE ?
The headquarters of PHARMACIE DU BOUT DU MONDE is located in PLOGOFF (29770), in the department Finistere.
Where to find the tax return of PHARMACIE DU BOUT DU MONDE ?
The tax return of PHARMACIE DU BOUT DU MONDE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU BOUT DU MONDE operate?
PHARMACIE DU BOUT DU MONDE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart